Analyst Zegbeh Jallah works at CAPITAL ONE and is covering the the Healthcare sector with 273 price targets and ratings documented since 2019 spanning on 21 stocks. Previously, Zegbeh Jallah worked at ROTH.
Zegbeh Jallah's average stock forecast success ratio is 19.43% with an average time for price targets to be met of 57.68 days.
Most recent stock forecast was given on RAPT, RAPT Therapeutics Inc. at 15-Mar-2023.
Analyst best performing recommendations are on OCGN (OCUGEN, INC).
The best stock recommendation documented was for OCGN (OCUGEN, INC) at 2/3/2021. The price target of $8 was fulfilled within 5 days with a profit of $5.19 (184.7%) receiving and performance score of 369.4.
Average potential price target upside
Currently, out of the existing stock ratings of Zegbeh Jallah - 4 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
0.4
$0.01 (2.56%)
7 months 6 days ago
2/2 (100%)
$0.51 (11.28%)
2
Buy
7 months 6 days ago
0/8 (0%)
$12.64 (79.14%)
Buy
12
7 months 7 days ago
0/4 (0%)
$10.17 (97.61%)
Buy
8 months 1 days ago
0/1 (0%)
$8.19 (140.96%)
Buy
11
8 months 2 days ago
0/2 (0%)
$8.27 (173.02%)
